日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A synergistic interaction between PRMT5 and LSD1 inhibitors in AML.

PRMT5 和 LSD1 抑制剂在急性髓系白血病中存在协同作用。

Param Nesteene Joy, Arceci Elisa, Fiorentino Francesco, Pignata Luca, Torre Denis, Gutiérrez-Trejo Nayeli, Fong Jia Yi, Goy Pierre-Alexis, Han Brenda Y, Lambona Chiara, Di Bello Elisabetta, Castiello Carola, Barone Marco, Schwarz Megan, Arrowsmith Cheryl, Ito Koichi, Scherle Peggy, Wee Dave Keng Boon, Ndoye Steven, Tabaglio Tommaso, Jeyasekharan Anand D, Lakshmanan Manikandan, Cirilli Roberto, Habisch Hansjörg, Madl Tobias, Mattevi Andrea, Valente Sergio, Mai Antonello, Guccione Ernesto

Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775

乐伐替尼联合帕博利珠单抗治疗既往接受过治疗的晚期子宫内膜癌:随机、3期研究309/KEYNOTE-775的5年结果

Makker, Vicky; Colombo, Nicoletta; Casado, Antonio; Santin, Alessandro D; Colomba, Emeline; Miller, David S; Fujiwara, Keiichi; Pignata, Sandro; Yonemori, Kan; Kim, Yong Man; Baron-Hay, Sally; Ray-Coquard, Isabelle; Shapira-Frommer, Ronnie; Kristeleit, Rebecca; Nishio, Shin; Suzuki, Shiro; Guerra Alía, Eva M; Sanli, Ulus A; Selle, Frederic; Shikama, Ayumi; Martínez Rodríguez, Jorge L; Arik, Zafer; Arican, Ali; Sebastianelli, Alexandra; Yu, Zhou; McKenzie, Jodi; Kruger, Stephan; Meng, Robin; Okpara, Chinyere E; Lorusso, Domenica

Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trial

多模式肿瘤非特异性ctDNA分析用于卵巢癌微小残留病灶检测和风险分层:MITO16a/MaNGO-OV2试验结果

Paracchini, L; Velle, A; Di Gennaro, P; Mannarino, L; Ancona, L; Lorusso, D; Cecere, S C; Colombo, N; Beltrame, L; Fagotti, A; Tasca, G; Piemontese, M; Arenare, L; Califano, D; Galdiero, F; Zadro, R; Chiodini, P; Perrone, F; Biagioli, E; D'Incalci, M; Romualdi, C; Pignata, S; Marchini, S

Bevacizumab in ovarian cancer: Clinical data and predictive and prognostic biomarkers

贝伐珠单抗治疗卵巢癌:临床数据及预测和预后生物标志物

Lamia, Maria Rosaria; Perri, Erica; Baldassarre, Gustavo; Pignata, Sandro; D'Alessio, Chiara; Limongello, Davide; Basso-Valentina, Francesca

Physical Activity, Nutritional Status, and Health-Related Quality of Life in Newly Diagnosed Cancer Patients: Evidence from the NUTRISCREEN Project

新确诊癌症患者的身体活动、营养状况和健康相关生活质量:来自 NUTRISCREEN 项目的证据

Porciello, Giuseppe; Crispo, Anna; Di Carlo, Francesco Pio Maria; Rocco, Paola; Luongo, Assunta; Russo, Natalia; Palumbo, Elvira; Vitale, Sara; Coluccia, Sergio; Prete, Melania; Di Lauro, Teresa; Abbadessa, Ludovica; Di Martino, Annabella; Mozzillo, Anna Licia; Racca, Emanuela; Piccirillo, Arianna; Di Giacomo, Vittoria; D'Amico, Maria; Fontana, Martina; Augustin, Livia S A; D'Errico, Davide; Coppola, Elisabetta; Stallone, Tiziana; Maiolino, Piera; Parascandolo, Ileana; Turrà, Valeria; Pignata, Sandro

CCDC6 Immunostaining in Conjunction with the Rad51 HRD Assay May Expand PARPi Treatment Eligibility in Patients with HGSOC

CCDC6免疫染色联合Rad51 HRD检测可能扩大PARP抑制剂治疗在高级别浆液性卵巢癌患者中的适用范围。

Daniela Criscuolo,Francesco Merolla,Benedetta Pellegrino,Luca Russolillo,Ilaria De Benedictis,Daniela Califano,Rosaria Catalano,Carmela Baviello,Silvia Varricchio,Sabrina C Cecere,Camilla Nero,Eleonora Palluzzi,Dionyssios Katsaros,Ettore D Capoluongo,Giovanni L Scaglione,Sergio Marchini,Daniela Russo,Anna Spina,Laura Arenare,Francesco Morra,Maria Marotta,Marialuisa A Vecchione,Alexandra Ingallinella,Francesco Perrone,Sandro Pignata,Angela Celetti

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial

一线乐伐替尼联合帕博利珠单抗对比化疗治疗晚期子宫内膜癌:一项随机、开放标签的III期试验

Marth, Christian; Moore, Richard G; Bidziński, Mariusz; Pignata, Sandro; Ayhan, Ali; Rubio, M Jesús; Beiner, Mario; Hall, Marcia; Vulsteke, Christof; Braicu, Elena Ioana; Sonoda, Kenzo; Wu, Xiaohua; Frentzas, Sophia; Mattar, André; Lheureux, Stephanie; Chen, Xiaojun; Hasegawa, Kosei; Magallanes-Maciel, Manuel; Choi, Chel Hun; Shalkova, Mariia; Kaen, Diego; Wang, Peng-Hui; Berger, Regina; Okpara, Chinyere E; McKenzie, Jodi; Yao, Lili; Orlowski, Robert; Khemka, Vivek; Gilbert, Lucy; Makker, Vicky

Long-term outcome in Wiskott-Aldrich syndrome and X-linked thrombocytopenia patients: an observational -prospective multi-center study of the Italian Primary Immune Deficiency Network (IPINET)

Wiskott-Aldrich 综合征和 X 连锁血小板减少症患者的长期预后:意大利原发性免疫缺陷网络 (IPINET) 的一项观察性前瞻性多中心研究

Soresina, Annarosa; Rondelli, Roberto; Notarangelo, Lucia Dora; Locatelli, Franco; Aiuti, Alessandro; Biffi, Alessandra; Rabusin, Marco; Pignata, Claudio; Menna, Giuseppe; Prete, Arcangelo; Faraci, Maura; Rovelli, Attilio; Conti, Francesca; Bertolini, Patrizia; Azzari, Chiara; Cancrini, Caterina; Zecca, Marco; Ferrua, Francesca; Cicalese, Maria Pia; Cecere, Francesco; Dotta, Laura; Martire, Baldassarre; Giliani, Silvia; Moratto, Daniele; Mazza, Cinzia; Plebani, Alessandro; Notarangelo, Luigi D; Pession, Andrea; Badolato, Raffaele; Fulvio, Fulvio

Peripheral Thyroid Hormones, Inflammatory and Skeletal Muscle Indexes in Advanced Cervical Cancer Treated With Cemiplimab

接受西米普利单抗治疗的晚期宫颈癌患者的外周甲状腺激素、炎症和骨骼肌指标

Tuninetti, Valentina; Virano, Elisa; Calvo, Amedeo; Carbone, Vittoria; Pisano, Carmela; Ducceschi, Monika; Turitto, Giacinto; Scandurra, Giuseppa; Petrella, Maria Cristina; Forestieri, Valeria; Petracchini, Massimo; Bianco, Alessandra; Cioffi, Raffaella; Mantiero, Mara; Paluzzi, Eleonora; Distefano, Maria Grazia; Martelli, Olga; Pignata, Sandro; Formica, Vincenzo; Loupakis, Fotios; Valabrega, Giorgio

HR-SC-an academic-developed machine learning framework to classify HRD-positive ovarian cancer patients and predict sensitivity to olaparib

HR-SC 是一个学术界开发的机器学习框架,用于对 HRD 阳性卵巢癌患者进行分类并预测其对奥拉帕尼的敏感性。

Beltrame, L; Mannarino, L; Sergi, A; Velle, A; Treilleux, I; Pignata, S; Paracchini, L; Harter, P; Scambia, G; Perrone, F; González-Martin, A; Berger, R; Arenare, L; Hietanen, S; Califano, D; Derio, S; Van Gorp, T; Dalessandro, M L; Fujiwara, K; Provansal, M; Lorusso, D; Buderath, P; Masseroli, M; Ray-Coquard, I; Pujade-Lauraine, E; Romualdi, C; D'Incalci, M; Marchini, S